Press release
Meningococcal Vaccines Market Estimated to Flourish by 2021
Meningococcal vaccines are used in the treatment of meningitis, septicemia, meningococcemia and pneumonia. Meningitis is characterized by inflammation of the membranes covering the brain and spinal cord. This type of inflammation is caused by infection of bacteria, viruses and by drugs.Based on various cause of the disease, meningitis is classified into two main types: non-infectious meningitis and infectious meningitis. Non-infectious meningitis is a type of aseptic meningitis. Aseptic meningitis is caused by something other than the bacteria that typically cause acute meningitis. Non-infectious meningitis does not spread from person to person. Infectious meningitis is further sub-divided into bacterial meningitis, fungal meningitis, viral meningitis and parasitic meningitis. Bacterial meningitis is extremely severe form of the disease which is caused by bacteria such as Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumonia.
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/3640
These bacteria can spread from person to person through coughing and sneezing. Viral meningitis is mainly occurred by diarrhea causing virus. Fungal meningitis is rare in healthy people. However, person who has an impaired immune system is more prevalent with this form of the disease.
Septicemia arises from infections throughout the body. It includes infections in the lungs, urinary tract and abdomen. Meningococcemia is also caused by bacterium Neisseria meningitidis.
The global meningococcal vaccines market is segmented into conjugate vaccines, polysaccharide vaccines and combination vaccines. Conjugate vaccines reduce incidences of bacterial meningitis. This is due to prolonged immunization influence of the vaccine which is developed for various serogroups of bacteria. Major brands of conjugate vaccines include MenAfriVac, Nimenrix, Menactra, Meningitec, NeisVac-C and Menveo.
Polysaccharide provides immunity for a short period of time. Major brands of polysaccharide vaccines include NmVac4, Menomune, Bi Meningo, Mencevax and Quadri Meningo.
Combination vaccines are prepared with the combination of other microorganism. Major brands of combination vaccines include Menitorix and MenHibrix.
In terms of geographic, North America dominates the global meningococcal vaccines market. This is due to increased healthcare awareness in the region. The U.S. represents the largest market for meningococcal vaccines followed by Canada in North America. In Europe, France, Germany and the U.K. holds major share of meningococcal vaccines market. However, Asia is expected to show high growth rates in the next five years in global meningococcal vaccines market. This is due to increasing awareness among people about meningitis in the region. Several government associations have launched various immunization programs and awareness campaigns to provide education about meningococcal disease. Japan, China and India are expected to be the fastest growing meningococcal vaccines markets in Asia.
To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/3640
In recent time, increased government support is key driver for the global meningococcal vaccines market. Various government associations have launched mandate immunization programs for school children. This increases the demand of meningococcal vaccines to provide immunity against meningococcal disease.
However, stringent regulations hamper the growth of global meningococcal vaccines market. Increasing mergers and acquisitions between manufacturing companies and government bodies and rapid product launches are some of the major trends of global meningococcal vaccines market.
Some of the major companies operating in the global meningococcal vaccines market are GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG, Sanofi SA, Pfizer, Inc. and Baxter International, Inc..
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Meningococcal Vaccines Market Estimated to Flourish by 2021 here
News-ID: 721688 • Views: …
More Releases from Persistence Market Research

Human Augmentation Market Expected to Surge at 21.2% CAGR Through 2032 - Persist …
The human augmentation market plays a pivotal role in enhancing human capabilities, performance, and quality of life. Human augmentation technologies encompass wearable devices, implantable devices, exoskeletons, neural interfaces, and bio-enhancement solutions that improve physical, cognitive, and sensory functions. These technologies are extensively applied in healthcare, defense, industrial operations, sports, and personal wellness, enabling humans to overcome physical limitations, enhance productivity, and improve safety. According to the latest study, the global…

Medical Implants Market Set to Soar to $196.4 Bn by 2032 at 7.1% CAGR
The medical implants market plays a critical role in improving patient outcomes, enhancing quality of life, and supporting advanced surgical interventions. These implants are extensively used in orthopedic, cardiovascular, dental, and neurosurgical procedures. They help restore functionality, reduce pain, and improve the longevity of treatment, making them indispensable in modern healthcare. According to the latest study by Persistence Market Research, the global medical implants market size is projected to rise…

Dental Imaging Market Booms with Rising Adoption of Advanced Technologies
The dental imaging market plays a critical role in enhancing diagnostic accuracy, treatment planning, and patient outcomes in modern dentistry. Dental imaging technologies, including intraoral, extraoral, panoramic, and cone-beam computed tomography (CBCT) systems, are extensively used in dental clinics, hospitals, and specialty centers. These systems improve visualization of teeth, bone structures, and soft tissues, enabling early detection of dental disorders, precise implant placement, and better orthodontic planning. According to the…

Hearing Aids Industry Poised for Boom with Market to Reach US$13.5 Bn by 2032
The hearing aids market plays a vital role in enhancing the quality of life for individuals with hearing impairments. These devices are extensively used across healthcare facilities, audiology centers, and homecare settings to improve auditory functions and communication abilities. Modern hearing aids incorporate advanced technologies such as digital signal processing, noise reduction, and wireless connectivity, making them indispensable for people suffering from partial or complete hearing loss. According to the…
More Releases for Meningo
Meningococcal Vaccines Market to Cross US$ 4.4 Billion Globally by 2022
New York, April 24: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Global Meningococcal Vaccines Market by Combination-, Conjugate-, Polysaccharide …
The global meningococcal vaccines market is estimated to reach US$ 4.3 Bn in 2021, expanding at a CAGR of 12.6% from 2017 to 2021, due to technological advancement and its rapid adoption worldwide.
Browse Meningococcal Vaccines Market by Meningococcal Combination Vaccines (Bexsero, Trumenba, MenHibrix, Menitorix); Meningococcal Conjugate Vaccines (Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT); and Meningococcal Polysaccharide Vaccine (Bi Meningo, Mencevax, Menomune, NmVac4, Quadri Meningo) and Forecast 2017-2021…
Meningococcal Vaccines Market Worth US$ 4.4 Billion Globally by 2022
New York, April 06: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Exceed US$ 4.4 Billion by 2022
New York, March 16: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Reach US$ 4.4 Billion by 2022
New York, March 08: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits…
Meningococcal Vaccines Market to Cross US$ 4.4 Billion by 2022
New York, February 27: Market Research Engine has published a new report titled as “Meningococcal Vaccines Market By Type Analysis (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, Men B Vaccines) and By Regional Analysis – Global Forecast by 2016 - 2022”
How Big is the Global Meningococcal Vaccines Market?
The Global Meningococcal Vaccines Market is expected to exceed more than US$ 4.4 billion by 2022 and will grow at a CAGR of more…